,
your personalized virtual assistant to find clinical trials. Go head, 
Susan A. Sajer, MD
Commonwealth Hematology-Oncology, PC - QuincyQuincy, Massachusetts - 02169 (978-287-3436) |
- CLINICAL TRIALS 6
- CONDITIONS15
- INTERVENTIONS18
- SINCE2005
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer Metastatic Prostate Cancer or Multiple Myeloma With Bone Involvement
March 2009 - May 2015
Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
April 2008 - June 2011
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
November 2008 - August 2011
Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
July 2006 - April 2024
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
November 2005 - June 2008
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB Stage II or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
June 2007 - July 2015
Breast Neoplasms
Colonic Neoplasms
Lung Neoplasms
Adenocarcinoma
Prostatic Neoplasms
Multiple Myeloma
Neoplasms, Plasma Cell
Neoplasms
Neoplasm Metastasis
Carcinoma
Colorectal Neoplasms
Carcinoma in Situ
Carcinoma, Intraductal, Noninfiltrating
Carcinoma, Ductal, Breast
Carcinoma, Ductal
Zoledronic Acid
Bevacizumab
Cisplatin
Docetaxel
Fluorouracil
Leucovorin Calcium
Gemcitabine Hydrochloride
Radiation Therapy
Lenalidomide
Pemetrexed Disodium
Oxaliplatin
Bortezomib
Dexamethasone
Trastuzumab
Cetuximab
Irinotecan Hydrochloride
Vinorelbine Ditartrate
Antiandrogen Therapy
